Methylation status of vault RNA 2-1 promoter is a predictor of glycemic response to glucagon-like peptide-1 analog therapy in type 2 diabetes mellitus.
Chia-Hung LinYun-Shien LeeYu-Yao HuangChi-Neu TsaiPublished in: BMJ open diabetes research & care (2021)
The glycemic response to GLP-1 analog treatment is associated with the methylation status of the VTRNA2-1 promoter and polymorphism of rs2346018.